Sunshine Biopharma earnings missed by $0.10, revenue fell short of estimates
NegativeFinancial Markets

Sunshine Biopharma reported earnings that missed expectations by $0.10, with revenue also falling short of estimates. The announcement, made on November 17, 2025, highlights challenges the company is facing in meeting financial targets. Investors may react negatively to this news, reflecting concerns about the company's performance and future growth prospects.
— via World Pulse Now AI Editorial System